Log in to save to my catalogue

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7073202

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management

About this item

Full title

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2020-02, Vol.21 (4), p.1517

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Mucopolysaccharidosis type IVA (MPS IVA, or Morquio syndrome type A) is an inherited metabolic lysosomal disease caused by the deficiency of the N-acetylglucosamine-6-sulfate sulfatase enzyme. The deficiency of this enzyme accumulates the specific glycosaminoglycans (GAG), keratan sulfate, and chondroitin-6-sulfate mainly in bone, cartilage, and it...

Alternative Titles

Full title

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7073202

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7073202

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms21041517

How to access this item